Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Nota del Director Editorial: En vivo desde Nueva York, les presentamos Psiquiatría y Salud Integral
1
x
$
0.00
Psychopharmacology Bulletin VOL 47 No. 4, 2017 - Full Issue Stacked PDF
1
x
$
60.00
View Cart
Checkout
Home
Persisting Psychosocial Impairments in Adults Being Treated with Medication for Attention Deficit/Hyperactivity Disorder
“Psychopharmacology Bulletin VOL 47 No. 4, 2017 – Full Issue Stacked PDF” has been added to your cart.
View cart
Persisting Psychosocial Impairments in Adults Being Treated with Medication for Attention Deficit/Hyperactivity Disorder
$
30.00
Persisting Psychosocial Impairments in Adults Being Treated with Medication for Attention Deficit/Hyperactivity Disorder quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Category:
VOL 47 No. 4 Articles - 2017
Tags:
adult ADHD
,
Alexandra Khachatryan
,
DSM-V
,
Emuella Flood
,
Norman Atkins
,
Phillip Sarocco
,
psychosocial impairments
,
social impairment
,
Thomas E. Brown
,
work impairment
Description
Description
Original Presentations
Persisting Psychosocial Impairments in Adults Being Treated with Medication for Attention Deficit/Hyperactivity Disorder
By
Thomas E. Brown, Emuella Flood, Phillip Sarocco, Norman Atkins, Alexandra Khachatryan
08-17_PB-47-4-2017_PB-Brown1
Related products
Escitalopram Induced SIADH in an Elderly Female: A Case Study
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 4, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Physical Activity Diminishes Symptomatic Decline in Chronic Schizophrenia: A Systematic Review
$
30.00
Add to cart
Details
Dextromethorphan in Cough Syrup: The Poor Man’s Psychosis
$
30.00
Add to cart
Details
Page load link
Go to Top
